Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.680
-0.080 (-4.55%)
At close: Oct 9, 2026, 4:00 PM EDT
1.690
+0.010 (0.60%)
After-hours: Oct 9, 2026, 7:54 PM EDT
Lexicon Pharmaceuticals Market Cap
Lexicon Pharmaceuticals has a market cap or net worth of $747.53 million as of October 9, 2026. It is the 12,155th most valuable company in the world and the 2,468th biggest in the United States. Its market cap has increased by 43.84% in one year.
Market Cap
747.53M
Enterprise Value
616.16M
1-Year Change
43.84%
Global Rank
Country Rank
#2,468 United States
Category
ChartMarket Cap Chart
Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $747.53M, a decrease of -16.09%. That is a compound annual growth rate of -0.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 747.50M | 78.87% |
| Dec 31, 2025 | 417.90M | 56.46% |
| Dec 31, 2024 | 267.10M | -28.72% |
| Dec 29, 2023 | 374.70M | 3.94% |
| Dec 30, 2022 | 360.50M | -38.54% |
| Dec 31, 2021 | 586.60M | 45.99% |
| Dec 31, 2020 | 401.80M | -8.89% |
| Dec 31, 2019 | 441.00M | -37.30% |
| Dec 31, 2018 | 703.30M | -32.58% |
| Dec 29, 2017 | 1.04B | -27.50% |
| Dec 30, 2016 | 1.44B | 4.32% |
| Dec 31, 2015 | 1.38B | 194.45% |
| Dec 31, 2014 | 468.40M | -49.30% |
| Dec 31, 2013 | 923.80M | -18.41% |
| Dec 31, 2012 | 1.13B | 159.94% |
| Dec 30, 2011 | 435.60M | -10.39% |
| Dec 31, 2010 | 486.10M | 62.74% |
| Dec 31, 2009 | 298.70M | 55.98% |
| Dec 31, 2008 | 191.50M | -53.80% |
| Dec 31, 2007 | 414.50M | 50.51% |
| Dec 29, 2006 | 275.40M | 16.89% |
| Dec 30, 2005 | 235.60M | -52.10% |
| Dec 31, 2004 | 491.90M | 33.02% |
| Dec 31, 2003 | 369.80M | 49.35% |
| Dec 31, 2002 | 247.60M | -58.67% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 762.51M |
| Annexon | 762.11M |
| Candel Therapeutics | 760.59M |
| Verastem | 758.92M |
| Inventiva | 756.65M |
| Gyre Therapeutics | 746.48M |
| Attovia Therapeutics | 740.01M |
| Solid Biosciences | 736.64M |